WEBULL
News
ANPCY
0.067
NaN%
--
CelLBxHealth Showcases CTC Diagnostic Advances at World ADC Conference
Reuters · 11/05/2025 07:00
BRIEF-Angle Appoints Peter Collins As Interim Chief Executive Officer
Reuters · 10/16/2025 06:37
ANGLE plc Appoints Peter Collins as Interim CEO and Klaas de Boer as Senior Board Advisor
Reuters · 10/16/2025 06:00
ANGLE plc to change name to CelLBxHealth plc
Reuters · 10/08/2025 06:00
ANGLE plc Announces Breakthrough Clinical Study Demonstrating Parsortix System's Ability to Detect Circulating Tumor Cells in Glioblastoma Patients
Reuters · 09/29/2025 06:00
Weekly Report: what happened at ANPCY last week (0908-0912)?
Weekly Report · 09/15/2025 11:48
Angle PLC Announces Board Changes
Barchart · 09/11/2025 21:30
ANGLE plc Reports Decline in Revenue and Increased Loss for H1 2025; EPS at (2.87) Pence
Reuters · 09/10/2025 08:42
Weekly Report: what happened at ANPCY last week (0901-0905)?
Weekly Report · 09/08/2025 11:50
Weekly Report: what happened at ANPCY last week (0825-0829)?
Weekly Report · 09/01/2025 11:44
Weekly Report: what happened at ANPCY last week (0818-0822)?
Weekly Report · 08/25/2025 11:58
ANGLE Partners With Myriad Genetics To Explore Extension Of Tissue-Based Companion Diagnostic Tests To Blood-Based CTC-DNA Testing
Benzinga · 08/20/2025 07:37
Weekly Report: what happened at ANPCY last week (0811-0815)?
Weekly Report · 08/18/2025 11:48
Weekly Report: what happened at ANPCY last week (0804-0808)?
Weekly Report · 08/11/2025 11:57
Weekly Report: what happened at ANPCY last week (0728-0801)?
Weekly Report · 08/04/2025 12:00
Weekly Report: what happened at ANPCY last week (0721-0725)?
Weekly Report · 07/28/2025 12:01
Weekly Report: what happened at ANPCY last week (0714-0718)?
Weekly Report · 07/21/2025 11:49
Weekly Report: what happened at ANPCY last week (0707-0711)?
Weekly Report · 07/14/2025 12:01
Weekly Report: what happened at ANPCY last week (0630-0704)?
Weekly Report · 07/07/2025 11:50
Weekly Report: what happened at ANPCY last week (0623-0627)?
Weekly Report · 06/30/2025 11:58
More
Webull provides a variety of real-time ANPCY stock news. You can receive the latest news about CELLBXHEALTH PLC through multiple platforms. This information may help you make smarter investment decisions.
About ANPCY
Cellbxhealth PLC, formerly ANGLE plc, is a global precision circulating tumor cell (CTC) intelligence company specializing in innovative circulating tumor cell solutions for use in research, drug development and clinical oncology. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.